Completed Diabetes, Hormones & Metabolism Heart, Stroke & Blood
11beta hydroxysteroid dehydrogenase type 1 and atherosclerosis risk.
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at University of Edinburgh.
View the original record at the funder ↗
Researchers
Jonathan Seckl (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
P450 oxidoreductase: Novel regulator of steroid synthesis and metabolism in health and disease
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1: A novel treatment for the Metabolic Syndrome
11ß-hydroxysteroid dehydrogenase type 1 inhibition as a novel treatment for peripheral arterial disease
How does 11B-hydroxysteroid dehydrogenase type I limit inflammation?
The 18kDa Translocator Protein rs6971 polymorphism and steroid synthesis: mechanism and implications for disease states
Original classification
Programme GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know